227 related articles for article (PubMed ID: 23315078)
1. IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.
Harper MS; Barrett BS; Smith DS; Li SX; Gibbert K; Dittmer U; Hasenkrug KJ; Santiago ML
J Immunol; 2013 Feb; 190(4):1583-90. PubMed ID: 23315078
[TBL] [Abstract][Full Text] [Related]
2. Effects of type I interferons on Friend retrovirus infection.
Gerlach N; Schimmer S; Weiss S; Kalinke U; Dittmer U
J Virol; 2006 Apr; 80(7):3438-44. PubMed ID: 16537611
[TBL] [Abstract][Full Text] [Related]
3. Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.
Santiago ML; Benitez RL; Montano M; Hasenkrug KJ; Greene WC
J Immunol; 2010 Jul; 185(2):1114-23. PubMed ID: 20566830
[TBL] [Abstract][Full Text] [Related]
4. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.
Tsuji-Kawahara S; Chikaishi T; Takeda E; Kato M; Kinoshita S; Kajiwara E; Takamura S; Miyazawa M
J Virol; 2010 Jun; 84(12):6082-95. PubMed ID: 20375169
[TBL] [Abstract][Full Text] [Related]
5. Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.
Barrett BS; Guo K; Harper MS; Li SX; Heilman KJ; Davidson NO; Santiago ML
Virology; 2014 Nov; 468-470():601-608. PubMed ID: 25303118
[TBL] [Abstract][Full Text] [Related]
6. Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.
Takeda E; Tsuji-Kawahara S; Sakamoto M; Langlois MA; Neuberger MS; Rada C; Miyazawa M
J Virol; 2008 Nov; 82(22):10998-1008. PubMed ID: 18786991
[TBL] [Abstract][Full Text] [Related]
7. Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction.
Barrett BS; Harper MS; Jones ST; Guo K; Heilman KJ; Kedl RM; Hasenkrug KJ; Santiago ML
Retrovirology; 2017 Apr; 14(1):25. PubMed ID: 28415995
[TBL] [Abstract][Full Text] [Related]
8. Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.
Li SX; Barrett BS; Guo K; Kassiotis G; Hasenkrug KJ; Dittmer U; Gibbert K; Santiago ML
Sci Rep; 2016 Feb; 6():20425. PubMed ID: 26846717
[TBL] [Abstract][Full Text] [Related]
9. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.
Santiago ML; Montano M; Benitez R; Messer RJ; Yonemoto W; Chesebro B; Hasenkrug KJ; Greene WC
Science; 2008 Sep; 321(5894):1343-6. PubMed ID: 18772436
[TBL] [Abstract][Full Text] [Related]
10. A Protein Antagonist of Activation-Induced Cytidine Deaminase Encoded by a Complex Mouse Retrovirus.
Singh GB; Byun H; Ali AF; Medina F; Wylie D; Shivram H; Nash AK; Lozano MM; Dudley JP
mBio; 2019 Aug; 10(4):. PubMed ID: 31409681
[TBL] [Abstract][Full Text] [Related]
11. The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3.
Kolokithas A; Rosenke K; Malik F; Hendrick D; Swanson L; Santiago ML; Portis JL; Hasenkrug KJ; Evans LH
J Virol; 2010 Oct; 84(20):10933-6. PubMed ID: 20702647
[TBL] [Abstract][Full Text] [Related]
12. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
Smith DS; Guo K; Barrett BS; Heilman KJ; Evans LH; Hasenkrug KJ; Greene WC; Santiago ML
PLoS Pathog; 2011 Oct; 7(10):e1002284. PubMed ID: 21998583
[TBL] [Abstract][Full Text] [Related]
13. Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.
Zhao W; Akkawi C; Mougel M; Ross SR
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641479
[TBL] [Abstract][Full Text] [Related]
14. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.
Santiago ML; Smith DS; Barrett BS; Montano M; Benitez RL; Pelanda R; Hasenkrug KJ; Greene WC
J Virol; 2011 Jan; 85(1):189-99. PubMed ID: 20980520
[TBL] [Abstract][Full Text] [Related]
15. Deaminase-Dead Mouse APOBEC3 Is an
Stavrou S; Zhao W; Blouch K; Ross SR
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the immunomodulatory and antiviral effects of the cytokine combination IFN-α and IL-7 in the lymphocytic choriomeningitis virus and Friend retrovirus mouse infection models.
Audigé A; Hofer U; Dittmer U; van den Broek M; Speck RF
Viral Immunol; 2011 Oct; 24(5):375-85. PubMed ID: 21929334
[TBL] [Abstract][Full Text] [Related]
17. SAMHD1 Promotes the Antiretroviral Adaptive Immune Response in Mice Exposed to Lipopolysaccharide.
Barrett B; Nguyen DH; Xu J; Guo K; Shetty S; Jones ST; Mickens KL; Shepard C; Roers A; Behrendt R; Wu L; Kim B; Santiago ML
J Immunol; 2022 Jan; 208(2):444-453. PubMed ID: 34893529
[TBL] [Abstract][Full Text] [Related]
18. Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection.
Li SX; Barrett BS; Harper MS; Heilman KJ; Halemano K; Steele AK; Guo K; Silverman RH; Santiago ML
Virology; 2013 Aug; 443(1):134-42. PubMed ID: 23725696
[TBL] [Abstract][Full Text] [Related]
19. Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.
Pillai SK; Abdel-Mohsen M; Guatelli J; Skasko M; Monto A; Fujimoto K; Yukl S; Greene WC; Kovari H; Rauch A; Fellay J; Battegay M; Hirschel B; Witteck A; Bernasconi E; Ledergerber B; Günthard HF; Wong JK;
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3035-40. PubMed ID: 22315404
[TBL] [Abstract][Full Text] [Related]
20. Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.
Lavender KJ; Gibbert K; Peterson KE; Van Dis E; Francois S; Woods T; Messer RJ; Gawanbacht A; Müller JA; Münch J; Phillips K; Race B; Harper MS; Guo K; Lee EJ; Trilling M; Hengel H; Piehler J; Verheyen J; Wilson CC; Santiago ML; Hasenkrug KJ; Dittmer U
J Virol; 2016 Jul; 90(13):6001-6013. PubMed ID: 27099312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
